Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

931 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in Japan.
Onitsuka T, Okada T, Hasegawa N, Tsuboi T, Iga JI, Yasui-Furukori N, Yamada N, Hori H, Muraoka H, Ohi K, Ogasawara K, Ochi S, Takeshima M, Ichihashi K, Fukumoto K, Iida H, Yamada H, Furihata R, Makinodan M, Takaesu Y, Numata S, Komatsu H, Hishimoto A, Kido M, Atake K, Yamagata H, Kikuchi S, Hashimoto N, Usami M, Katsumoto E, Asami T, Kubota C, Matsumoto J, Miura K, Hirano Y, Watanabe K, Inada K, Hashimoto R. Onitsuka T, et al. Among authors: hasegawa n. J Clin Psychopharmacol. 2023 Jul-Aug 01;43(4):365-368. doi: 10.1097/JCP.0000000000001704. Epub 2023 May 23. J Clin Psychopharmacol. 2023. PMID: 37216369
Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project.
Ichihashi K, Hori H, Hasegawa N, Yasuda Y, Yamamoto T, Tsuboi T, Iwamoto K, Kishimoto T, Horai T, Yamada H, Sugiyama N, Nakamura T, Tsujino N, Nemoto K, Oishi S, Usami M, Katsumoto E, Yamamori H, Tomita H, Suwa T, Furihata R, Inagaki T, Fujita J, Onitsuka T, Miura K, Matsumoto J, Ohi K, Matsui Y, Takaesu Y, Hashimoto N, Iga J, Ogasawara K, Yamada H, Watanabe K, Inada K, Hashimoto R. Ichihashi K, et al. Among authors: hasegawa n. Neuropsychopharmacol Rep. 2020 Sep;40(3):281-286. doi: 10.1002/npr2.12122. Epub 2020 Jun 30. Neuropsychopharmacol Rep. 2020. PMID: 32602667 Free PMC article.
Unmet needs of patients with major depressive disorder - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
Iida H, Iga J, Hasegawa N, Yasuda Y, Yamamoto T, Miura K, Matsumoto J, Murata A, Ogasawara K, Yamada H, Hori H, Ichihashi K, Hashimoto N, Ohi K, Yasui-Furukori N, Tsuboi T, Nakamura T, Usami M, Furihata R, Takaesu Y, Iwamoto K, Sugiyama N, Kishimoto T, Tsujino N, Yamada H, Hishimoto A, Nemoto K, Atake K, Muraoka H, Katsumoto E, Oishi S, Inagaki T, Ito F, Imamura Y, Kido M, Nagasawa T, Numata S, Ochi S, Iwata M, Yamamori H, Fujita J, Onitsuka T, Yamamura S, Makinodan M, Fujimoto M, Takayanagi Y, Takezawa K, Komatsu H, Fukumoto K, Tamai S, Yamagata H, Kubota C, Horai T, Inada K, Watanabe K, Kawasaki H, Hashimoto R. Iida H, et al. Among authors: hasegawa n. Psychiatry Clin Neurosci. 2020 Dec;74(12):667-669. doi: 10.1111/pcn.13143. Epub 2020 Oct 9. Psychiatry Clin Neurosci. 2020. PMID: 32881226 Free PMC article. No abstract available.
Relationship between white matter microstructure and work hours.
Matsumoto J, Fukunaga M, Miura K, Nemoto K, Koshiyama D, Okada N, Morita K, Yamamori H, Yasuda Y, Fujimoto M, Hasegawa N, Watanabe Y, Kasai K, Hashimoto R. Matsumoto J, et al. Among authors: hasegawa n. Neurosci Lett. 2021 Jan 1;740:135428. doi: 10.1016/j.neulet.2020.135428. Epub 2020 Oct 18. Neurosci Lett. 2021. PMID: 33086092
Effects of age and sex on eye movement characteristics.
Takahashi J, Miura K, Morita K, Fujimoto M, Miyata S, Okazaki K, Matsumoto J, Hasegawa N, Hirano Y, Yamamori H, Yasuda Y, Makinodan M, Kasai K, Ozaki N, Onitsuka T, Hashimoto R. Takahashi J, et al. Among authors: hasegawa n. Neuropsychopharmacol Rep. 2021 Jun;41(2):152-158. doi: 10.1002/npr2.12163. Epub 2021 Feb 21. Neuropsychopharmacol Rep. 2021. PMID: 33615745 Free PMC article.
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.
Numata S, Nakataki M, Hasegawa N, Takaesu Y, Takeshima M, Onitsuka T, Nakamura T, Edagawa R, Edo H, Miura K, Matsumoto J, Yasui-Furukori N, Kishimoto T, Hori H, Tsuboi T, Yasuda Y, Furihata R, Muraoka H, Ochi S, Nagasawa T, Kyou Y, Murata A, Katsumoto E, Ohi K, Hishimoto A, Inada K, Watanabe K, Hashimoto R. Numata S, et al. Among authors: hasegawa n. Neuropsychopharmacol Rep. 2021 Jun;41(2):199-206. doi: 10.1002/npr2.12173. Epub 2021 Mar 11. Neuropsychopharmacol Rep. 2021. PMID: 33704931 Free PMC article.
Positive association between insight and attitudes toward medication in Japanese patients with schizophrenia: Evaluation with the Schedule for Assessment of Insight (SAI) and the Drug Attitude Inventory - 10 Questionnaire (DAI-10).
Ito S, Matsumoto J, Sakai Y, Miura K, Hasegawa N, Yamamori H, Ishimaru K, Kim Y, Hashimoto R. Ito S, et al. Among authors: hasegawa n. Psychiatry Clin Neurosci. 2021 May;75(5):187-188. doi: 10.1111/pcn.13215. Epub 2021 Mar 31. Psychiatry Clin Neurosci. 2021. PMID: 33715260 Free article. No abstract available.
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project.
Hashimoto N, Yasui-Furukori N, Hasegawa N, Ishikawa S, Numata S, Hori H, Iida H, Ichihashi K, Furihata R, Murata A, Tsuboi T, Takeshima M, Kyou Y, Komatsu H, Kubota C, Ochi S, Takaesu Y, Usami M, Nagasawa T, Hishimoto A, Miura K, Matsumoto J, Ohi K, Yamada H, Inada K, Watanabe K, Shimoda K, Hashimoto R. Hashimoto N, et al. Among authors: hasegawa n. Asian J Psychiatr. 2021 Sep;63:102744. doi: 10.1016/j.ajp.2021.102744. Epub 2021 Jul 15. Asian J Psychiatr. 2021. PMID: 34325252 Free article.
Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.
Yasui-Furukori N, Muraoka H, Hasegawa N, Ochi S, Numata S, Hori H, Hishimoto A, Onitsuka T, Ohi K, Hashimoto N, Nagasawa T, Takaesu Y, Inagaki T, Tagata H, Tsuboi T, Kubota C, Furihata R, Iga JI, Iida H, Miura K, Matsumoto J, Yamada H, Watanabe K, Inada K, Shimoda K, Hashimoto R. Yasui-Furukori N, et al. Among authors: hasegawa n. Neuropsychopharmacol Rep. 2022 Mar;42(1):3-9. doi: 10.1002/npr2.12218. Epub 2021 Dec 2. Neuropsychopharmacol Rep. 2022. PMID: 34854260 Free PMC article.
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study.
Furihata R, Otsuki R, Hasegawa N, Tsuboi T, Numata S, Yasui-Furukori N, Kashiwagi H, Hori H, Ochi S, Muraoka H, Onitsuka T, Komatsu H, Takeshima M, Hishimoto A, Nagasawa T, Takaesu Y, Nakamura T, Asami T, Miura K, Matsumoto J, Ohi K, Yasuda Y, Iida H, Ogasawara K, Hashimoto N, Ichihashi K, Yamada H, Watanabe K, Inada K, Hashimoto R. Furihata R, et al. Among authors: hasegawa n. Sleep Med. 2022 Jan;89:23-30. doi: 10.1016/j.sleep.2021.11.005. Epub 2021 Nov 22. Sleep Med. 2022. PMID: 34875519 Free article.
931 results